![]() |
![]() |
Legal status
Patent expired
(51) | INT.CL. | C07D 239/48 | (2006.01) |
C07D 409/12 | (2006.01) | ||
C07D 403/12 | (2006.01) | ||
C07D 405/12 | (2006.01) | ||
C07D 413/12 | (2006.01) | ||
C07D 417/12 | (2006.01) | ||
A61K 31/505 | (2006.01) | ||
A61P 13/00 | (2006.01) |
(11) | Number of the document | 1725540 |
(13) | Kind of document | T |
(96) | European patent application number | 05715558.2 |
Date of filing the European patent application | 2005-02-25 | |
(97) | Date of publication of the European application | 2006-11-29 |
(45) | Date of publication and mention of the grant of the patent | 2012-09-12 |
(46) | Date of publication of the claims translation | 2013-01-25 |
(86) | Number | PCT/EP2005/002020 |
Date | 2005-02-25 |
(87) | Number | WO 2005/095359 |
Date | 2005-10-13 |
(30) | Number | Date | Country code |
550499 P | 2004-03-05 | US |
(72) |
CARTER, David, Scott, US
DILLON, Michael, Patrick, US
HAWLEY, Ronald, Charles, US
LIN, Clara, Jeou, Jen, US
PARISH, Daniel, Warren, US
BROKA, Chris, Allen, US
JAHANGIR, Alam, US
|
(73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Diaminopirimidinai, kaip P2X3 ir P2X2/3 antagonistai |
DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS |
Payment date | Validity (years) | Amount | |
2024-01-23 | 347.00 EUR |